Surgical rates in the era of biological therapy: up, down or unchanged?
Fiche publication
Date publication
juillet 2017
Journal
Current opinion in gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Olivera P, Spinelli A, Gower-Rousseau C, Danese S, Peyrin-Biroulet L
Lien Pubmed
Résumé
The aim of this review is to summarize data regarding surgical trends in inflammatory bowel disease in the prebiologic and biologic era, with a focus on population-based studies and randomized controlled trials (RCTs).
Mots clés
Biological Therapy, statistics & numerical data, Humans, Inflammatory Bowel Diseases, therapy, Proctocolectomy, Restorative, statistics & numerical data, Randomized Controlled Trials as Topic, Remission Induction, Secondary Prevention, Tumor Necrosis Factor-alpha, antagonists & inhibitors
Référence
Curr. Opin. Gastroenterol.. 2017 Jul;33(4):246-253